164 related articles for article (PubMed ID: 5731442)
1. [The experimental basis for several problems in the enteric method of vaccination. I. Immunogenicity of typhoid Vi- and O-antigens in enteric vaccination].
Kovaleva NI; Khatuntseva NV; Mironova MV
Zh Mikrobiol Epidemiol Immunobiol; 1968 Aug; 45(8):65-71. PubMed ID: 5731442
[No Abstract] [Full Text] [Related]
2. [The experimental basis of various problems in enteral vaccination. 2. Effectiveness of Vi- and O-antigen typhoid vaccines when used enterally].
Kovaleva NI; Mironova MV; Khatuntseva NV
Zh Mikrobiol Epidemiol Immunobiol; 1969; 46(6):9-13. PubMed ID: 5346282
[No Abstract] [Full Text] [Related]
3. [The importance of Vi- and O-antigens for formation of immunity to typhoid infections].
Kolobova LF; Pershin BB
Zh Mikrobiol Epidemiol Immunobiol; 1970 Dec; 47(12):97-101. PubMed ID: 5511394
[No Abstract] [Full Text] [Related]
4. Specific and cross-reactive immune response to oral Salmonella Typhi Ty21a and parenteral Vi capsular polysaccharide typhoid vaccines administered concomitantly.
Pakkanen SH; Kantele JM; Savolainen LE; Rombo L; Kantele A
Vaccine; 2015 Jan; 33(3):451-8. PubMed ID: 25433216
[TBL] [Abstract][Full Text] [Related]
5. Evolution of the typhoid immunity along one year after intradermal vaccination.
Dimache G; Croitoru M; Ciordaş C; Velea V
Arch Roum Pathol Exp Microbiol; 1986; 45(2):147-52. PubMed ID: 3800632
[No Abstract] [Full Text] [Related]
6. Immune response of infants and preschool children to typhoid vaccine given intradermally or subcutaneously.
Mohandas V; Cherian T; Sridharan G; Simoes EA; Pereira SM; John TJ
BMJ; 1989 Jan; 298(6667):162-3. PubMed ID: 2493838
[No Abstract] [Full Text] [Related]
7. [Determination of the immunogenic properties of corpuscular typhoid vaccine following oral administration].
Faĭn VI; Balaian VD; Meshalova AN
Zh Mikrobiol Epidemiol Immunobiol; 1966 Jun; 43(6):32-6. PubMed ID: 6004906
[No Abstract] [Full Text] [Related]
8. Studies on infection and immunity in experimental typhoid fever. III. Effect of prophylactic immunization.
GAINES S; LANDY M; EDSALL G; MANDEL AD; TRAPANI RJ; BENENSON AS
J Exp Med; 1961 Sep; 114(3):327-42. PubMed ID: 13702952
[TBL] [Abstract][Full Text] [Related]
9. [Typhoid vaccination from an immunological point of view].
Günther O
Arb Paul Ehrlich Inst Georg Speyer Haus Ferdinand Blum Inst Frankf A M; 1970; 65():1-14. PubMed ID: 4926019
[No Abstract] [Full Text] [Related]
10. Oral immunisation against typhoid fever in Indonesia with Ty21a vaccine.
Simanjuntak CH; Paleologo FP; Punjabi NH; Darmowigoto R; Soeprawoto ; Totosudirjo H; Haryanto P; Suprijanto E; Witham ND; Hoffman SL
Lancet; 1991 Oct; 338(8774):1055-9. PubMed ID: 1681365
[TBL] [Abstract][Full Text] [Related]
11. Typhoid immunisation.
Ghai OP; Paul VK
Indian J Pediatr; 1984; 51(408):71-6. PubMed ID: 6378786
[No Abstract] [Full Text] [Related]
12. Review of current typhoid fever vaccines, cross-protection against paratyphoid fever, and the European guidelines.
Zuckerman JN; Hatz C; Kantele A
Expert Rev Vaccines; 2017 Oct; 16(10):1029-1043. PubMed ID: 28856924
[TBL] [Abstract][Full Text] [Related]
13. Immunogenicity and safety of the Vi-CRM197 conjugate vaccine against typhoid fever in adults, children, and infants in south and southeast Asia: results from two randomised, observer-blind, age de-escalation, phase 2 trials.
Bhutta ZA; Capeding MR; Bavdekar A; Marchetti E; Ariff S; Soofi SB; Anemona A; Habib MA; Alberto E; Juvekar S; Khan RM; Marhaba R; Ali N; Malubay N; Kawade A; Saul A; Martin LB; Podda A
Lancet Infect Dis; 2014 Feb; 14(2):119-29. PubMed ID: 24290843
[TBL] [Abstract][Full Text] [Related]
14. A comparative study of the effectiveness of corpuscular and chemical paratyphoid B vaccines in monkey experiments using subcutaneous and parenteral administration.
Stepanova LK; Gekker VD; Stasilevish ZK; Sergeyeva NS
J Hyg Epidemiol Microbiol Immunol; 1972; 16(4):386-97. PubMed ID: 4629402
[No Abstract] [Full Text] [Related]
15. [Production of a complex chemical typhoid vaccine containing O-, Vi, and H-antigens].
Gekker VD; Sergeeva NS
Zh Mikrobiol Epidemiol Immunobiol; 1973 Jan; 50(1):14-8. PubMed ID: 4780106
[No Abstract] [Full Text] [Related]
16. Enteric Fever and Invasive Nontyphoidal Salmonellosis--9th International Conference on Typhoid and Invasive NTS Disease, Bali, Indonesia, April 30-May 3, 2015.
Khan MI; Katrinak C; Freeman A; Franco-Paredes C
Emerg Infect Dis; 2016 Apr; 22(4):. PubMed ID: 27366797
[No Abstract] [Full Text] [Related]
17. Efficient vaccination strategy against typhoid fever.
Arya SC
Vaccine; 2000 May; 18(22):2321-2. PubMed ID: 10905949
[No Abstract] [Full Text] [Related]
18. Antibody response to the protein antigens of "Salmonella typhi" during typhoid infection and following vaccination with a live oral typhoid vaccine Ty21a.
Chau PY; Tsang RS
Dev Biol Stand; 1983; 53():29-31. PubMed ID: 6873471
[TBL] [Abstract][Full Text] [Related]
19. Immunogenicity of a new Salmonella Typhi Vi polysaccharide vaccine--vax-TyVi--in Cuban school children and teenagers.
Azze RF; Rodríguez JC; Iniesta MG; Marchena XR; Alfonso VM; Padrón FT
Vaccine; 2003 Jun; 21(21-22):2758-60. PubMed ID: 12798615
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of vi-tetanus toxoid conjugated typhoid vaccine (PedaTyph™) in Indian children: School based cluster randomized study.
Mitra M; Shah N; Ghosh A; Chatterjee S; Kaur I; Bhattacharya N; Basu S
Hum Vaccin Immunother; 2016 Apr; 12(4):939-45. PubMed ID: 26901576
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
